chr11-134157049-G-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_015261.3(NCAPD3):c.4221C>A(p.His1407Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 1,613,574 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_015261.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD3 | NM_015261.3 | c.4221C>A | p.His1407Gln | missense_variant | 32/35 | ENST00000534548.7 | NP_056076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD3 | ENST00000534548.7 | c.4221C>A | p.His1407Gln | missense_variant | 32/35 | 1 | NM_015261.3 | ENSP00000433681 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 1590AN: 152022Hom.: 13 Cov.: 32
GnomAD3 exomes AF: 0.00941 AC: 2362AN: 251126Hom.: 15 AF XY: 0.00922 AC XY: 1252AN XY: 135724
GnomAD4 exome AF: 0.0128 AC: 18731AN: 1461434Hom.: 119 Cov.: 30 AF XY: 0.0126 AC XY: 9140AN XY: 727030
GnomAD4 genome AF: 0.0105 AC: 1590AN: 152140Hom.: 13 Cov.: 32 AF XY: 0.00978 AC XY: 727AN XY: 74358
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | NCAPD3: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
NCAPD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at